Tenax Therapeutics, Inc. (TENX) KPIs and segments
Close on Nov 13, 2026Market cap $60.63MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Tenax Therapeutics's business
Tenax Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Tenax Therapeutics's fiscal year ends April 30 — FY2013 = CY2012 (calendar year).
| Add to chart | Metric | FY2013 CY2012 | FY2012 CY2011 |
|---|---|---|---|
United States($M) | 0.09 | 0.36 | |
Latin America($M) | -0.01 | ||
Europe($M) | -0.03 | ||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2013-06-26.
See a number that looks wrong?